Moderna submits data to FDA on vaccine booster
Moderna has submitted initial data to the U.S. Food and Drug Administration on its vaccine booster, the pharmaceutical company announced Wednesday.
Its booster candidate would be half the dose (50 micrograms) of the original dosing (two shots of 100 micrograms each).
Federal officials have said they hope to begin administering booster shots for many Americans starting on Sept. 20, with the third shot at least eight months after the second.
The FDA has only authorized booster shots of Pfizer's and Moderna's COVID-19 vaccines for people who are immunocompromised. The Centers for Disease Control and Prevention's independent advisory board also recommended booster shots for those with weakened immune systems.
Pfizer is also seeking authorization for a third dose of its COVID-19 vaccine. The FDA announced Wednesday it will hold a public meeting of its independent advisory committee on Sept. 17 to discuss the application.
-ABC News' Eric Strauss